Induced Pluripotent Stem Cell-derived Alveolar Type II Heterogeneity: Revealed by SFTPC Expression

Hongmei Mou
DOI: https://doi.org/10.1165/rcmb.2021-0242ED
IF: 7.748
2021-10-01
American Journal of Respiratory Cell and Molecular Biology
Abstract:Human induced pluripotent stem cell (hiPSC) differentiation offers great opportunities to generate diverse, personalized, and disease-specific cells for future cell-based therapies and drug development. In addition, it also provides a powerful tool for understanding human organogenesis and disease pathogenesis. In studying the lung, numerous stepwise differentiation protocols have been reported to successfully convert hiPSCs to various types of airway epithelia and lamella body–containing alveolar epithelia. Alveoli are an important part of the respiratory system, playing a crucial role in oxygen and carbon dioxide exchange. Human and mouse alveolar epithelium consists of type I and type II cells. Alveolar epithelial type II cells (AEC2s) are the facultative progenitors of lung alveoli, as they maintain the alveolar epithelium through self-renewal and differentiation into alveolar epithelial type I cells for homeostatic maintenance and damage repair. In addition, the AEC2 is responsible for secreting surfactant to modulate alveolar surface tension. Thus, it is of great interest to generate a large quantity of functional and expandable AEC2s for the understanding of alveolar development, tissue regeneration, and lung disorders.
biochemistry & molecular biology,cell biology,respiratory system
What problem does this paper attempt to address?